Requip prolonged release

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	9

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 9 of 9 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-002827-17-EE (EUCTR)	23/04/2013	08/02/2013	A fixed dose, dose response study for ropinirole prolonged release(PR) in patients with early stage ...	A fixed dose, dose response study for ropinirole prolonged release(PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: REQUIP-MODUTAB , 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propo ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
2	EUCTR2011-002828-41-EE (EUCTR)	23/04/2013	08/02/2013	A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients ...	A fixed dose, dose-response study of ropinirole prolonged release(PR) as adjunctive treatment to L-d ...	Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propos ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Taiwan;Estonia;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
3	EUCTR2011-002828-41-SK (EUCTR)	27/03/2013	04/03/2013	A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients ...	A fixed dose, dose-response study of ropinirole prolonged release(PR) as adjunctive treatment to L-d ...	Advanced Parkinson's disease. MedDRA version: 16.0;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: RequipModutab, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propose ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Estonia;Taiwan;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
4	EUCTR2012-000801-64-GB (EUCTR)	09/02/2013	26/11/2012	A study of the effects of medication on memory in Parkinson's Disease	A Phase IV Acceptability and Feasibility Trial of the Effects of Medication on Memory in Idiopathic ...	Idiopathic Parkinson's Disease MedDRA version: 17.0;Level: LLT;Classification code 10013113;Term: Di ...	Trade Name: Mirapexin extended releasevarious strengths Product Name: Pramipexole dihydrochloride mon ...	University Hospital of North Staffordshire	Keele University	Not Recruiting			Female: yes Male: yes	55	Phase 4	United Kingdom
5	NCT01371682 (ClinicalTrials.gov)	September 18, 2009	10/6/2010	A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Rel ...	An Open Label Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole P ...	Parkinson Disease	Drug: Ropinirole XL	GlaxoSmithKline	NULL	Completed	18 Years	50 Years	All	50	Phase 1	Belgium
6	EUCTR2009-015833-66-IT (EUCTR)	20/01/2009	18/04/2012	Ropinirole 24h prolonged releaseand motor fluctuations: a study to control the wearing-off induced b ...	Ropinirole 24h prolonged releaseand motor fluctuations: a study to control the wearing-off induced b ...	Parkinson's Disease MedDRA version: 14.1;Level: LLT;Classification code 10013113;Term: Disease Parki ...	Trade Name: REQUIP*28CPR 8MG R.P. INN or Proposed INN: ROPINIROLE Other descriptive name: NA Trade Name ...	CASA DI CURA PRIVATA S.RAFFAELE - PISANA	NULL	Not Recruiting			Female: yes Male: yes			Italy
7	EUCTR2006-006209-94-DE (EUCTR)	15/03/2007	26/01/2007	An open label, repeat dose, dose escalation study conducted in Parkinson’s Disease patients to chara ...	An open label, repeat dose, dose escalation study conducted in Parkinson’s Disease patients to chara ...	Parkinson's disease MedDRA version: 9.1;Level: LLT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Requip-Modutab Product Name: Requip-Modutab Product Code: SK&F101468 INN or Proposed INN: R ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	36		Germany
8	NCT00331149 (ClinicalTrials.gov)	June 20, 2006	26/5/2006	A Comparison of Ropinirole Immediate ReleaseWith Ropinirole Prolonged Releasein Patients With Advanc ...	A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment With Ro ...	Parkinson Disease	Drug: Ropinirole prolonged release;Drug: ropinirole immediate release	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	343	Phase 3	Bulgaria;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;South Africa; ...
9	EUCTR2005-005423-34-IT (EUCTR)	08/05/2006	03/10/2006	A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ro ...	A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ro ...	Parkinson disease MedDRA version: 6.1;Level: PT;Classification code 10061536	Product Name: ropinirole PR/XR tablets Product Code: SKF-101468A INN or Proposed INN: Ropinirole Trade ...	GlaxoSmithKline R D	NULL	Not Recruiting			Female: yes Male: yes	516		Hungary;United Kingdom;Czech Republic;Germany;Spain;Italy

First Previous1Next Last